1Atrial Fibrillation Investigators.Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials[].Archives of Internal Medicine.1994
2Wolf PA,Abbott RD,Kennel WB.Atrial fibrillation as an independent risk factor for stroke: the Framingham study[].Stroke.1991
3Laupacis A,Albers G,Dalen J,et al.Antithrombotic therapy in atrial fibrillation.4th ACCP consensus conference on antithrombotic therapy[].Chest.1995
4EAFT Study Group.European atrial fibrillation trial: secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and a recent transient ischemic attack or minor ischemic stroke[].The Lancet.1993
5Stroke Prevention in Atrial Fibrillation Investigators.Bleeding during antithrombotic therapy in patients with atrial fibrillation[].Archives of Internal Medicine.1996
6Hylek EM,Skates SJ,Sheehan MA,et al.An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation[].The New England Journal of Medicine.1996
7Ezekowitz MD,Levine JA.Preventing stroke in patients with atrial fibrillation[].The Journal of The American Medical Association.1999
8Bjerkelund CJ,Orning OM.The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation[].The American Journal of Cardiology.1969
9Muramatsu H,Shimura T.Incidence of cerebral thromboembolic infarction associated with paroxysmal and persistent or permanent atrial fibrillation[].Journalism Assn of Community College.2000
10Manning WJ,Silverman DI,Keighley CS,et al.Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4. 5-year study[].Journalism Assn of Community College.1995
